{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:06:28Z","timestamp":1774789588402,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cbi.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T18:27:34Z","timestamp":1476210454000},"page":"176-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Analysis of hematopathology and alteration of JAK1\/STAT3\/STAT5 signaling axis in experimental myelodysplastic syndrome"],"prefix":"10.1016","volume":"260","author":[{"given":"Suchismita","family":"Daw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritam","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2016.10.010_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.V100.3.791","article-title":"Myelodysplastic syndrome is not merely \u201cpreleukemia\u201d","volume":"100","author":"Albitar","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1200\/JCO.2010.31.1175","article-title":"Unraveling the molecular pathophysiology of myelodysplastic syndromes","volume":"29","author":"Bejar","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cbi.2016.10.010_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.cbi.2016.10.010_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2405030","article-title":"Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes","volume":"22","author":"Buesche","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cbi.2016.10.010_bib5","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2011.044628","article-title":"Ring sideroblasts and sideroblastic anemias","volume":"96","author":"Cazzola","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.cbi.2016.10.010_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes\u2014coping with ineffective haematopoiesis","volume":"352","author":"Cazzoala","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cbi.2016.10.010_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12595-014-0132-5","article-title":"Pathophysiological scenario of hematopoietic disorders:a comparative study of aplastic anemia, myelodysplastic syndrome and leukemia in experimental animals","volume":"69","author":"Chatterjee","year":"2015","journal-title":"Proc. Zool. Soc."},{"key":"10.1016\/j.cbi.2016.10.010_bib8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/sj.leu.2404009","article-title":"Mutations of genes in the receptor tyrosine kinase (RTK)\/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia","volume":"19","author":"Christiansen","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2016.10.010_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.21320","article-title":"Historical perspective and clinical implications of the Pelger-Huet cell","volume":"84","author":"Cunningham","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.cbi.2016.10.010_bib10","doi-asserted-by":"crossref","first-page":"e20590","DOI":"10.1371\/journal.pone.0020590","article-title":"NAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes","volume":"6","author":"Das","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cbi.2016.10.010_bib11","first-page":"229","article-title":"Sca-1\/c-Kit receptor expression and apoptosis pattern in ENU induced MDS mice","volume":"4","author":"Das","year":"2009","journal-title":"J.\u00a0Stem Cells"},{"issue":"2","key":"10.1016\/j.cbi.2016.10.010_bib12","first-page":"49","article-title":"The bone marrow stem stromal imbalance-a key feature of disease progression in case of myelodysplastic mouse model","volume":"5","author":"Das","year":"2010","journal-title":"J.\u00a0Stem Cells"},{"issue":"1","key":"10.1016\/j.cbi.2016.10.010_bib13","first-page":"43","article-title":"Benzene exposure - an experimental machinery for induction of myelodysplastic syndrome: stem cell and stem cell niche analysis in the bone marrow","volume":"7","author":"Das","year":"2012","journal-title":"J.\u00a0Stem Cells"},{"issue":"5","key":"10.1016\/j.cbi.2016.10.010_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1139\/bcb-2012-0109","article-title":"Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): why hypercellular marrow strongly favors accelerated apoptosis","volume":"91","author":"Das","year":"2013","journal-title":"Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.cbi.2016.10.010_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","article-title":"Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes","volume":"27","author":"Della Porta","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"5018","key":"10.1016\/j.cbi.2016.10.010_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1650499","article-title":"Protein tyrosine phosphatases: a diverse family of intracellular and and transmembrane enzymes","volume":"253","author":"Fischer","year":"1991","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.cbi.2016.10.010_bib17","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-06-4409","article-title":"The akt\/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation","volume":"67","author":"Follo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2016.10.010_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2050-7771-1-5","article-title":"Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application","volume":"1","author":"Furqan","year":"2013","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cbi.2016.10.010_bib19","first-page":"241","article-title":"Roles of protein kinases and phosphatases in signal transduction","volume":"44","author":"Hardie","year":"1990","journal-title":"Symp. Soc. Exp. Biol."},{"key":"10.1016\/j.cbi.2016.10.010_bib20","doi-asserted-by":"crossref","first-page":"a011205","DOI":"10.1101\/cshperspect.a011205","article-title":"The JAK\/STAT pathway","volume":"4","author":"Harrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cbi.2016.10.010_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1309\/AJCPN4G1IZPABRLH","article-title":"A\u00a0dissection of the CD45\/side scatter \u201cblast gate\u201d","volume":"137","author":"Harrington","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.cbi.2016.10.010_bib22","doi-asserted-by":"crossref","first-page":"e2015035","DOI":"10.4084\/mjhid.2015.035","article-title":"Importance of classical morphology in the diagnosis of myelodysplastic syndrome","volume":"7","author":"Invernizzi","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.cbi.2016.10.010_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35053086","article-title":"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling","volume":"409","author":"Irie-Sasaki","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cbi.2016.10.010_bib24","first-page":"39","article-title":"Transplacental production with Ethyinitrosourea of neoplasms of the nervous system in Sprague-Dawley Rats","volume":"63","author":"Koestner","year":"1971","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2016.10.010_bib25","series-title":"Biochemistry of Signal Transduction and Regulation","author":"Krauss","year":"2014"},{"issue":"3","key":"10.1016\/j.cbi.2016.10.010_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-2478(03)00028-2","article-title":"Role of biomodulators and involvement of protein tyrosine kinase on stem cell migration in normal and leukaemic mice","volume":"86","author":"Law","year":"2003","journal-title":"Immunol. Lett."},{"issue":"17","key":"10.1016\/j.cbi.2016.10.010_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1074-7613(02)00336-9","article-title":"STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation","author":"Lee","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2016.10.010_bib28","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.04.014","article-title":"Epidemiology of myelodysplastic syndromes","volume":"125","author":"Ma","year":"2012","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.cbi.2016.10.010_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/AJCPCRK3MOAOJ6AT","article-title":"CD71 ( transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens","volume":"134","author":"Marsee","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cbi.2016.10.010_bib30","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cbi.2016.10.010_bib31","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1309\/AJCPRCXX4R0YHKWV","article-title":"Myelodysplastic syndromes","volume":"132","author":"Orazi","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"issue":"24","key":"10.1016\/j.cbi.2016.10.010_bib33","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1182\/blood-2012-03-415356","article-title":"Prognostic irrelevance of ring sideroblast percentage in World Health Organization\u2013defined myelodysplastic syndromes without excess blasts","volume":"119","author":"Patnaik","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signalling Pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.cbi.2016.10.010_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2016.10.010_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V90.2.597","article-title":"Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor","volume":"90","author":"Shimoda","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cbi.2016.10.010_bib37","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of Jak\u2013stat signalling in the immune system","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2016.10.010_bib38","series-title":"Human Physiology","author":"Silverthorn","year":"2007"},{"issue":"6","key":"10.1016\/j.cbi.2016.10.010_bib39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3324\/haematol.11471","article-title":"The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia","volume":"92","author":"Steensma","year":"2007","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.cbi.2016.10.010_bib40","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2016.10.010_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0167-4889(91)90043-W","article-title":"CD45: a leukocyte-specific member of the protein tyrosine phosphatase family","volume":"1095","author":"Trowbridge","year":"1991","journal-title":"Biochem. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.cbi.2016.10.010_bib42","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/humrep\/dep068","article-title":"Evaluation of male fertility potential by Toluidine Blue test for sperm chromatin structure assessment","volume":"24","author":"Tsarev","year":"2009","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.cbi.2016.10.010_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.18632\/oncotarget.185","article-title":"Standards and impact of hematopathology in myelodysplastic syndromes (MDS)","author":"Valent","year":"2010","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cbi.2016.10.010_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2005.12.017","article-title":"JAK\/STAT signal transduction: regulators and implication in hematological malignancies","volume":"71","author":"Valentino","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2016.10.010_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/asheducation-2006.1.199","article-title":"Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes","author":"Vardiman","year":"2006","journal-title":"Hematol. Am. Soc. Hematol."},{"key":"10.1016\/j.cbi.2016.10.010_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.2003.04.182","article-title":"Additional prognostic value of bone marrow histology in patients subclassified according to the international prognostic scoring system for myelodysplastic syndromes","volume":"21","author":"Verburgh","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cbi.2016.10.010_bib47","first-page":"4","article-title":"STAT5 in hematopoietic stem cell biology and transplantation","volume":"2","author":"Wang","year":"2013","journal-title":"Landes Biosci. JAK-STAT"},{"key":"10.1016\/j.cbi.2016.10.010_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V95.1.19","article-title":"The Jak-Stat pathway in normal and perturbed hematopoiesis","volume":"95","author":"Ward","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/156800907781662284","article-title":"Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches","volume":"7","author":"Warlick","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.cbi.2016.10.010_bib50","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1073\/pnas.0237137100","article-title":"STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity","volume":"100","author":"Welte","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.cbi.2016.10.010_bib51","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1182\/blood-2007-12-127480","article-title":"Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemiaassociated with reduced transferrin receptor gene expression","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cbi.2016.10.010_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3324\/haematol.2012.069385","article-title":"Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?","volume":"98","author":"Beurlet","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cbi.2016.10.010_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.hoc.2010.02.002","article-title":"Mouse models of myelodysplastic syndrome","volume":"24","author":"Beachy","year":"2010","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"7","key":"10.1016\/j.cbi.2016.10.010_bib54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.leukres.2011.03.007","article-title":"Mouse models of myelodysplastic syndromes","volume":"35","author":"Wegrzyn","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cbi.2016.10.010_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-016-0235-8","article-title":"GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways","volume":"9","author":"Guerenne","year":"2016","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.cbi.2016.10.010_bib56","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/sj.leu.2401887","article-title":"Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice","volume":"14","author":"Louz","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2016.10.010_bib57","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1182\/blood-2002-08-2484","article-title":"Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1","volume":"101","author":"Pineault","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib58","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature03915","article-title":"Role of nucleophosmin in embryonic development and tumorigenesis","volume":"437","author":"Grisendi","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2016.10.010_bib60","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2003-09-3262","article-title":"Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+\/\u2212SHIP\u2212\/\u2212 mice: a novel model of myelodysplasia","volume":"103","author":"Moody","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2016.10.010_bib61","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1172\/JCI24177","article-title":"Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms","volume":"115","author":"Futterer","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"issue":"6101","key":"10.1016\/j.cbi.2016.10.010_bib62","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.cbi.2016.10.010_bib63","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1182\/blood-2008-10-182626","article-title":"Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis","volume":"113","author":"Chan","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cbi.2016.10.010_bib64","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1182\/blood-2007-08-109942","article-title":"Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model","volume":"111","author":"Li","year":"2008","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.cbi.2016.10.010_bib65","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2012-07-445635","article-title":"BCL-2 inhibition with ABT-737 prolongs survival in an NRAS\/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells","volume":"122","author":"Beurlet","year":"2013","journal-title":"Blood"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716304409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716304409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:42:38Z","timestamp":1757857358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279716304409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":65,"alternative-id":["S0009279716304409"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2016.10.010","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of hematopathology and alteration of JAK1\/STAT3\/STAT5 signaling axis in experimental myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}